We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov Menu

Blood, Hair and Lung Concentrations of Metals and Metalloids in Patients With Lung Cancer or Chronic Obstructive Pulmonary Disease (Métaux/Poumons)

This study has been completed.
ClinicalTrials.gov Identifier:
First Posted: September 24, 2013
Last Update Posted: May 3, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Hopital Foch
Prospective research to study the relationship between concentrations of metals/metalloids in blood, hair and lung tissue with the occurence of lung cancer or chronic obstructive pulmonary disease.

Condition Intervention
Lung Cancer Chronic Obstructive Pulmonary Disease Emphysema Lung Surgery Procedure: Lung surgery

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Basic Science
Official Title: Relationship Between Blood, Hair and Lung Metals/Metalloids Concentration (Cadmium, Iron, Copper, Nickel, Chrome, Arsenic, Vanadium, Beryllium, and Zinc) and Lung Cancer or Chronic Obstructive Pulmonary Disease.

Resource links provided by NLM:

Further study details as provided by Hopital Foch:

Primary Outcome Measures:
  • Metals/metalloids concentration [ Time Frame: Blood, hair and lung tissue are sampled during lung surgery ]

Enrollment: 251
Study Start Date: August 2011
Study Completion Date: March 2014
Primary Completion Date: March 2014 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Pulmonary cancer Procedure: Lung surgery


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years to 75 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Patients of 18 to 75 years of age.
  • Patients admitted for lung resection (either cancerous or non-cancerous) or lung transplant

Exclusion Criteria:

  • Patients with mental or physical conditions that prevent them giving their agreement for the study
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01949181

Hopital Foch
Suresnes, Ile de France, France, 92150
CHU de Poitiers, Chirurgie Cardiaque et Thoracique
Poitiers, France, 86000
Sponsors and Collaborators
Hopital Foch
Study Chair: Stanislas Grassin Delyle Hôpital Foch
  More Information

Responsible Party: Hopital Foch
ClinicalTrials.gov Identifier: NCT01949181     History of Changes
Other Study ID Numbers: 2010/37
First Submitted: September 19, 2013
First Posted: September 24, 2013
Last Update Posted: May 3, 2016
Last Verified: May 2016

Keywords provided by Hopital Foch:
Lung cancer
Chronic obstructive pulmonary disease

Additional relevant MeSH terms:
Lung Neoplasms
Lung Diseases
Lung Diseases, Obstructive
Pulmonary Disease, Chronic Obstructive
Respiratory Tract Neoplasms
Thoracic Neoplasms
Neoplasms by Site
Respiratory Tract Diseases
Pathologic Processes